Synthesis of 4-(Phenylamino)pyrimidine Derivatives as ATP-Competitive Protein Kinase Inhibitors with Potential for Cancer Chemotherap

Authors: Rewcastle G.W.; Denny W.A.; Showalter H.D.H.

Source: Current Organic Chemistry, Volume 4, Number 7, July 2000 , pp. 679-706(28)

Publisher: Bentham Science Publishers

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The 4-(phenylamino)pyrimidine pharmacophore is found in a variety of different compounds that function as ATP-competitive inhibitors of several important protein kinase enzymes. Specific inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase have received the most attention, and several elaborations of the fundamental 4-(phenyl?amino)??pyrimidine pharma?co?phore have now been reported as potent and selective inhibitors of this class of enzyme. Three separate pharmaceutical companies have now entered quinazoline EGFR inhibitors into clinical trials for the treatment of cancer, demonstrating the competitive nature of this area. Recent work with vascular endothelial growth factor (VEGF) and cyclin-dependent kinase (CDK) inhibitors has shown that the field is still expanding, and will undoubtably continue to show potential for some time to come. This review article concentrates on the synthetic approaches and chemical procedures that have been used for the production of these novel pharmaceutical agents.

Keywords: Synthesis; ATP Competitive; Protein kinase inhibitors; Cancer chemotherapy; Protein kinase enzymes; epidermal growth factor; Vascular endothelial growth factor; Cyclin dependent kinase; CDK inhibitors; Pharmaceutical agents; Cyclic GMP phosphodiesterase; Corticotropin releasing factor; Irreersible inhibitors; Quinazolines; Dimroth rearrangement; Azaquinazolines; Tricyclic quinazolines; Linear tricyclic quinazolines; Non-Liner tricyclic quinazolines; Fused five membered ring pyrimidine; Purines; Tyrosine kinase

Language: English

Document Type: Review article

DOI: 10.2174/1385272003376094

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.10 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A